2Wolley KL, Gibson PG, carty K, et al. Eosinophils apptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med, 1996; 154:237 ~ 243.
3Finnerty JP, Lee C, Willson S, et al. Effect of theophylline on inflammatory cells and cytokines in asthmatic subjects. Eur Respir J, 1996 ;9:1672 ~ 1676.
4Yamashita R, Kitahara H, Kanemitsu T, et al. Eosinophil cationic protein in the sera of patients with Mycoplasma pnemonia [J]. Pediatr Infect Dis J, 1994, 13(5): 379-381.
5Koller DY, Nilsson M, enander I, et al. Serum Eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase inCelation to pulmonary fuuction in oystic fibrosis [J]. Clin ExpAllergy, 1998,28(2): 241-248.
8Yano T, Tehikama Y, Komatu S, et al. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma [J]. Am J Respir Crit Med, 1994, 149(5): 1348-1353.
9Fujisawa T, Terala A, Atsuta J, et al. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma [J]. Clin Exp Allergy,1998, 28(1): 19-25.
2Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen [J] . Clin Microbiol Rev, 2004, 17 (4): 697-728.
3Defilippi AC, Silvestri M, Giacchino R, et al. Changes in blood eosinophil numbers during mycoplasma pneu- moniae infection in wheezing and non-wheezing, atopic and non-atopic children [ J] . Pediatr Int, 2008, 50: 718-721.